Ottawa, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The market for single-use assemblies is heavily influenced by the pharmaceutical sector's expanding need. Since single-use biorefinery systems boost process efficiency and lower the expenses associated with sterilizing, cleaning, and maintaining steel culture systems, the bulk of pharmaceutical businesses are increasingly implementing this technique.
Get the report sample PDF@ https://www.precedenceresearch.com/sample/2526
The single-use bioprocessing device is employed in a variety of biopharmaceutical activities, including mixing, filtering, purification, & storing. The biopharma industry is also expanding quickly. Around 20% of the worldwide pharmaceuticals industry is made up solely of biopharmaceuticals. the widespread application of pharmaceuticals as chemotherapeutic drugs, including, but not limited to, vaccinations, allergic agents, and cell treatments. Cancer patients can also receive treatment with it. Thus, the need for single-use bioprocessing systems is being greatly increased by the quick development of biopharmaceuticals. In the approaching years, industry growth is anticipated to be fueled by the rising elderly population around the world. The United Nations estimates that by 2050, almost 1.50 billion people worldwide will be 65 years of age or older. The senior population is more susceptible to chronic diseases, thus there will be a significant increase in demand for and usage of biopharmaceutical drugs, which will fuel the expansion of the worldwide single-use biorefinery industry.
Regional snapshots:
Base on geography, the North America has held revenue share of around 37.4% in 2022.
North America held the largest market share of single-use components. North America holds a sizeable market share thanks to its well-established pharmaceutical sector, the wide availability of Single-Use Assembly provided by regional market players, and the expanding production of biologic drugs and biologics in the area. With low market restrictions, the national pharmaceutical research and marketing climate in the US is among some of the friendliest in the world. Because of the favorable local climate, the sophisticated pharmaceuticals and biotechnology sectors are much more inclined to contribute the largest amount of a single-use assembling industry.
Customise this study as per your requirement - https://www.precedenceresearch.com/customization/2526
| Report Coverage | Details |
| North America Revenue Share | 37.4% in 2022 |
| Europe Revenue Share | 29% in 2022 |
| Biopharmaceuticals & pharmaceutical businesses Segment Share | 46% in 2022 |
| Key Players | Antylia Scientific, Corning Incorporated, Danaher Corporation, Avantor, Inc., Kuhner AG, Lonza, Meissner Filtration Products, Merck KGaA, Newage Industries, Entegris, Flexbiosys, Pall Corporation, Parker-Hannifin Corporation, Repligen Corporation, Romynox, Saint-Gobain Performance Plastics, Sartorius Stedim Biotech, Thermo Fisher Scientific, Inc. and Others |
Report Highlights:
- In 2022, the filtering assembly market was in the lead. Filtration assembly has been encouraged to be used for bulk as well as final fill processes due to improved regulatory possibilities and the requirement to reduce the danger of contaminants.
- Over the course of the projected period, the bag assembly sector is anticipated to rise at a profitable CAGR. Benefits such as not requiring verification and cleaning reduced shipping costs due to lighter packages, and minimal upkeep and capital investment costs are what fuel the segment's expansion.
- The sector of filtration applications held a greater revenue share. Due to advantages such as being ready to utilize and time & expense, single-use assemblies are being used for filtering more and more frequently than traditional filtration. The category selling bespoke solutions had the largest revenue share. Numerous businesses provide tailored solutions to accelerate drug research and pharmaceutical production.
- The pharmaceutical & biotechnology enterprises end-user segment dominated the global market. The expansion of current pharmaceutical manufacturing plants drives the growth of single-use assemblies. Throughout the forecast timeframe, the CROs and or CMOS sector is anticipated to increase at the quickest CAGR.
- CMOS has been incorporating single-use technologies into most or all of its bioprocesses in recent years. Single-use vehicles’ ability to enable short turnaround times, flexibility between production runs, and a variety of client engagements can increase CMO effectiveness and lower overall expenses.
Market Dynamics:
Drivers:
Major competitors in the worldwide single-use assembly market are paying more attention to the development and marketing of technically cutting-edge single-use assembling solutions with streamlined workflows, straightforward operation, and ease of deployment. Although single-use assemblies are crucial to both small & large-scale pharmaceutical production, there has been an increase in expenditures on biopharmaceutical development and research again for products. Due to their advantages, such as lowered materials cross-contamination danger and the absence of additional sterilization, single-use components are becoming more and more common.
Restraints:
Comprised of three components were compounds that can be removed from primary sources using appropriate solvents within strict laboratory settings, as opposed to leachable, which are chemicals found in pharmaceutical products as a result of leaching from seals, containers, and basic processes. Hence, leachable can be viewed as a subset of the emotion associated. Soluble and easily retrievable properties are frequently associated with elastomer or polymeric materials because these materials need chemicals to help with durability and the production of constituent materials.
Opportunities:
Due to its advantages, the single-use assembly has grown in popularity over the last ten years. Furthermore, to the advantageous regulatory environment and the economies of scale in developing countries like China, India, and South Korea, many pharmaceutical and biotechnology companies anticipate growing their single-use production factories to make these countries a hub for biocatalytic insourcing. This is further supported by the rising level of investments made in developing countries by significant market players. By collaborating alongside Wego Pharmaceutical to boost its manufacturing capacity in China, for instance, Cytiva was able to improve its distribution system in the APAC area.
Challenges:
The majority of end users, such as large research institutions and pharmaceutical companies, require several single-use parts to execute many manufacturing operations and research inquiries simultaneously. These tests and operations take place in environments with rising temperatures. single-use assembly made of stabilizer-containing plastics including polymers which are most likely to degrade in trace amounts via extracting and leaching. Cross-contamination of materials is now more likely. Therefore, serious worries about chemicals and leachable are limiting the market growth of single-use assembly.
Related Reports
- Single-use Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
- Single-Use Bioprocessing Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2030
- Laboratory Filtration Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
- Pharmaceutical Filtration Market - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032
Recent developments:
- The fully united strategy and construction atmosphere of Sonderanlagenbau HOF and Sartorius amalgamated in December 2021. The corporations would conjoin to embrace the straight-up platter freeze-thaw machines in Sartorius' invention choice to afford an occupied stripe of satisfactory freeze-thaw provisions and apparatus.
- Thermo Fisher Technical proclaimed the HyPeak chromatographical construction in October 2021 as a single-use chromatographical process for bioprocessing. The innovative approach was formed to exertion privileged the Emerson Delta-V mechanical net, empowering fixing for expertise assignment whereas safeguarding usage throughout downriver events to enhancement creation yield.
- In September 2022, Parker Hannifin acquired the worldwide British people occupational, Meggitt. By manufacturing this attainment, the business wanted to upsurge its development likely, figure out an extra exciting corporate, and suggest more ground-breaking answers for together cutting-edge maneuverability and spotless tech.
- Sartorius bought Albumedix, a firm created on learning, in its wholeness in August 2022. The corporation supposed that by constructing just this attainment, it would increase and strengthen its standing as an earner of leading-edge broadcasting that contains broadcasting and critical subsidiary fundamentals.
- In September 2021, Saint Gobain developed Equflow, an important breadwinner of flowmeters. With this attainment, the assembly would progress its single-line abilities by participating in Outflow’s fluid nursing results across entirely of its industries.
- In Dec 2021 Avantor prolonged its universal footmark in Massachusetts with the introduction of an unused, single-use logistics capability in the City of Westminster. After this local expansion, the corporation desired to reinforce its worldwide biopharma source system. Furthermore, the novel capability would accomplish circulation and logistics, permitting the corporation to apply its present possessions crosswise to North America.
- Avantor, an innovator in the making of single-use bio-catalytic belongings & assemblage, developed RIM Bio in June of 2021. This contract aims to contribute to the corporation in healthier helping its patrons by attracting its single-use manufacture, promotion, and cleanroom abilities through the EMEA section.
Market Segmentation
By Product
- Bag Assemblies
- Filtration Assemblies
- Tubing Assemblies
- Bottle Assemblies
- Others
By Application
- Filtration
- Storage
- Cell Culture & Mixing
- Fill-finish Applications
- Sampling
- Others
By Solution
- Customized
- Standard
By End-User
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutes
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/2526
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333
About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research
https://www.facebook.com/precedenceresearch
https://twitter.com/Precedence_R
